Report Detail
Global Angioedema Treatment Market Insights, Forecast to 2025
- RnM2641358 |
- 12 March, 2019 |
- Global |
- 111 Pages |
- QYResearch |
- Pharma & Healthcare
The global Angioedema Treatment market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Angioedema Treatment market based on company, product type, end user and key regions.
This report studies the global market size of Angioedema Treatment in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Angioedema Treatment in these regions.
This research report categorizes the global Angioedema Treatment market by top players/brands, region, type and end user. This report also studies the global Angioedema Treatment market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
AstraZeneca
F.Hoffmann-La Roche AG
Valeant Pharmaceuticals International
GlaxoSmithKline
AstraZeneca
Sanofi SA
Merck＆Co
Market size by Product
Antihistamines
Corticosteroids
Others
Market size by End User
Hospitals
Clinics
Research Organizations
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Angioedema Treatment market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Angioedema Treatment market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Angioedema Treatment companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Angioedema Treatment submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Angioedema Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Angioedema Treatment market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Angioedema Treatment Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Angioedema Treatment Market Size Growth Rate by Product
- 1.4.2 Antihistamines
- 1.4.3 Corticosteroids
- 1.4.4 Others
- 1.5 Market by End User
- 1.5.1 Global Angioedema Treatment Market Size Growth Rate by End User
- 1.5.2 Hospitals
- 1.5.3 Clinics
- 1.5.4 Research Organizations
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Angioedema Treatment Market Size
- 2.1.1 Global Angioedema Treatment Revenue 2014-2025
- 2.1.2 Global Angioedema Treatment Sales 2014-2025
- 2.2 Angioedema Treatment Growth Rate by Regions
- 2.2.1 Global Angioedema Treatment Sales by Regions
- 2.2.2 Global Angioedema Treatment Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Angioedema Treatment Sales by Manufacturers
- 3.1.1 Angioedema Treatment Sales by Manufacturers
- 3.1.2 Angioedema Treatment Sales Market Share by Manufacturers
- 3.1.3 Global Angioedema Treatment Market Concentration Ratio (CR5 and HHI)
- 3.2 Angioedema Treatment Revenue by Manufacturers
- 3.2.1 Angioedema Treatment Revenue by Manufacturers (2014-2019)
- 3.2.2 Angioedema Treatment Revenue Share by Manufacturers (2014-2019)
- 3.3 Angioedema Treatment Price by Manufacturers
- 3.4 Angioedema Treatment Manufacturing Base Distribution, Product Types
- 3.4.1 Angioedema Treatment Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Angioedema Treatment Product Type
- 3.4.3 Date of International Manufacturers Enter into Angioedema Treatment Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Angioedema Treatment Sales by Product
- 4.2 Global Angioedema Treatment Revenue by Product
- 4.3 Angioedema Treatment Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Angioedema Treatment Breakdown Data by End User
6 North America
- 6.1 North America Angioedema Treatment by Countries
- 6.1.1 North America Angioedema Treatment Sales by Countries
- 6.1.2 North America Angioedema Treatment Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Angioedema Treatment by Product
- 6.3 North America Angioedema Treatment by End User
7 Europe
- 7.1 Europe Angioedema Treatment by Countries
- 7.1.1 Europe Angioedema Treatment Sales by Countries
- 7.1.2 Europe Angioedema Treatment Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Angioedema Treatment by Product
- 7.3 Europe Angioedema Treatment by End User
8 Asia Pacific
- 8.1 Asia Pacific Angioedema Treatment by Countries
- 8.1.1 Asia Pacific Angioedema Treatment Sales by Countries
- 8.1.2 Asia Pacific Angioedema Treatment Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Angioedema Treatment by Product
- 8.3 Asia Pacific Angioedema Treatment by End User
9 Central & South America
- 9.1 Central & South America Angioedema Treatment by Countries
- 9.1.1 Central & South America Angioedema Treatment Sales by Countries
- 9.1.2 Central & South America Angioedema Treatment Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Angioedema Treatment by Product
- 9.3 Central & South America Angioedema Treatment by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Angioedema Treatment by Countries
- 10.1.1 Middle East and Africa Angioedema Treatment Sales by Countries
- 10.1.2 Middle East and Africa Angioedema Treatment Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Angioedema Treatment by Product
- 10.3 Middle East and Africa Angioedema Treatment by End User
11 Company Profiles
- 11.1 AstraZeneca
- 11.1.1 AstraZeneca Company Details
- 11.1.2 Company Business Overview
- 11.1.3 AstraZeneca Angioedema Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 AstraZeneca Angioedema Treatment Products Offered
- 11.1.5 AstraZeneca Recent Development
- 11.2 F.Hoffmann-La Roche AG
- 11.2.1 F.Hoffmann-La Roche AG Company Details
- 11.2.2 Company Business Overview
- 11.2.3 F.Hoffmann-La Roche AG Angioedema Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 F.Hoffmann-La Roche AG Angioedema Treatment Products Offered
- 11.2.5 F.Hoffmann-La Roche AG Recent Development
- 11.3 Valeant Pharmaceuticals International
- 11.3.1 Valeant Pharmaceuticals International Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Valeant Pharmaceuticals International Angioedema Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Valeant Pharmaceuticals International Angioedema Treatment Products Offered
- 11.3.5 Valeant Pharmaceuticals International Recent Development
- 11.4 GlaxoSmithKline
- 11.4.1 GlaxoSmithKline Company Details
- 11.4.2 Company Business Overview
- 11.4.3 GlaxoSmithKline Angioedema Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 GlaxoSmithKline Angioedema Treatment Products Offered
- 11.4.5 GlaxoSmithKline Recent Development
- 11.5 AstraZeneca
- 11.5.1 AstraZeneca Company Details
- 11.5.2 Company Business Overview
- 11.5.3 AstraZeneca Angioedema Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 AstraZeneca Angioedema Treatment Products Offered
- 11.5.5 AstraZeneca Recent Development
- 11.6 Sanofi SA
- 11.6.1 Sanofi SA Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Sanofi SA Angioedema Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Sanofi SA Angioedema Treatment Products Offered
- 11.6.5 Sanofi SA Recent Development
- 11.7 Merck＆Co
- 11.7.1 Merck＆Co Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Merck＆Co Angioedema Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Merck＆Co Angioedema Treatment Products Offered
- 11.7.5 Merck＆Co Recent Development
12 Future Forecast
- 12.1 Angioedema Treatment Market Forecast by Regions
- 12.1.1 Global Angioedema Treatment Sales Forecast by Regions 2019-2025
- 12.1.2 Global Angioedema Treatment Revenue Forecast by Regions 2019-2025
- 12.2 Angioedema Treatment Market Forecast by Product
- 12.2.1 Global Angioedema Treatment Sales Forecast by Product 2019-2025
- 12.2.2 Global Angioedema Treatment Revenue Forecast by Product 2019-2025
- 12.3 Angioedema Treatment Market Forecast by End User
- 12.4 North America Angioedema Treatment Forecast
- 12.5 Europe Angioedema Treatment Forecast
- 12.6 Asia Pacific Angioedema Treatment Forecast
- 12.7 Central & South America Angioedema Treatment Forecast
- 12.8 Middle East and Africa Angioedema Treatment Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Angioedema Treatment Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Angioedema Treatment. Industry analysis & Market Report on Angioedema Treatment is a syndicated market report, published as Global Angioedema Treatment Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Angioedema Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
